SCHEMBL18593382

SCHEMBL18593382

CC(C)(C)c1cc(-n2cc3ccccc3c2)c(O)c(C(C)(C)C)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.44
▸ CYP3A4 P08684 2/20 0.44
▸ CYP2C9 P11712 2/20 0.44
▸ CYP2C19 P33261 2/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ HSP90AA1 P07900 1/20 0.40
▸ ALOX5 P09917 3/20 0.38
▸ PTGS2 P35354 3/20 0.38
▸ CA2 P00918 3/20 0.36
▸ CA1 P00915 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.35
▸ POLB P06746 1/20 0.35
▸ TYR P14679 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ PTPN1 P18031 1/20 0.35
▸ GAA P10253 2/20 0.34
▸ PTGS1 P23219 1/20 0.34
▸ XBP1 P17861 1/20 0.34
▸ MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18593380 0.80 CYP1A2 (0.42) TSHRCYP3A4CYP2C9CYP2C19CYP1A2
SCHEMBL14703066 0.80 CYP2C19 (0.38) TSHRCYP3A4CYP2C9CYP2C19CYP1A2
SCHEMBL13376130 0.77 TSHR (0.39) TSHRCYP3A4CYP2C9CYP2C19CYP1A2
SCHEMBL18612721 0.77 HSP90AA1 (0.36) TSHRCYP3A4CYP2C9CYP2C19CYP1A2
SCHEMBL18612719 0.77 CYP1A2 (0.41) TSHRCYP3A4CYP2C9CYP2C19CYP1A2
SCHEMBL9002281 0.76 TSHR (0.46) TSHRCYP3A4CYP2C9CYP2C19CYP1A2
SCHEMBL29708 0.74 NPC1 (0.49) TSHRCYP3A4CYP2C9CYP2C19CYP1A2
SCHEMBL29350736 0.74 NPC1 (0.49) TSHRCYP3A4CYP2C9CYP2C19CYP1A2
SCHEMBL12733166 0.72 TSHR (0.39) TSHRCYP3A4CYP2C9CYP2C19CYP1A2
SCHEMBL8986512 0.71 CA2 (0.61) TSHRCYP3A4CYP2C9CYP2C19CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9856208-B2 Method for producing an arene with an aromatic C—N bond ortho to an aromatic C—O bond THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2018-01-02 — — US disclosed
US-20170066711-A1 METHOD FOR PRODUCING AN ARENE WITH AN AROMATIC C-N BOND ORTHO TO AN AROMATIC C-O BOND THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2017-03-09 — — US disclosed
US-20170066711-A1 METHOD FOR PRODUCING AN ARENE WITH AN AROMATIC C-N BOND ORTHO TO AN AROMATIC C-O BOND THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2017-03-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170066711-A1 METHOD FOR PRODUCING AN ARENE WITH AN AROMATIC C-N BOND ORTHO TO AN AROMATIC C-O BOND AOX1, NOX4, NOXO1 TSHR 4454/4885CYP3A4 137/4885CYP2C9 131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback